Completing the Transformation of DSM

Jean-Pierre Jeannet and Hein Schreuder

Chapter 13 in From Coal to Biotech, 2015, pp 233-253 from Springer

Abstract: Abstract The CSD of 2005, and in particular its acceleration by the new CEO Feike Sijbesma in 2007, aimed to complete the transformation of DSM. Remaining businesses in the Industrial Chemicals were targeted for divestment. At the same time, ambitious targets were set to boost innovation as well as DSM’s presence in emerging economies. When, despite the financial-economic crisis in this period, the company was able to execute these priorities successfully, the Board felt able to announce that DSM’s transformation had been completed in 2010. The chapter concludes with a reflection on DSM’s evolutionary transformation, as conducted through subsequent ‘strategic learning cycles’ initiated by intensive Corporate Strategy Dialogues.

Keywords: Open Innovation; Business Group; Performance Material; Biomedical Material; Manage Board (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-662-46299-7_13

Ordering information: This item can be ordered from
http://www.springer.com/9783662462997

DOI: 10.1007/978-3-662-46299-7_13

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().